Request for Information (RFI): Commercial Off-the-Shelf Task Management Tool

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

FOOD AND DRUG ADMINISTRATION

Contract Value

Not provided

Codes & Classification
Solicitation Number

FDA-RFI-2026-032726

NAICS

-

Classification Code

-

Additional Details
Set Aside

None

Place of Performance

Maryland, UNITED STATES

SourceSAM
Documents3
The U.S. Food and Drug Administration (FDA), operating under the Department of Health and Human Services, has issued a Special Notice in the form of a Request for Information (RFI) to gather technical and business insights from industry regarding Commercial Off-the-Shelf (COTS) task management solutions. This RFI, identified as FDA-RFI-2026-032726, specifically seeks information on products capable of supporting the FDA Executive Secretariat’s correspondence and task management needs. The primary objective of this procurement activity is to assess the marketplace for readily available COTS tools that can efficiently handle the complex requirements associated with managing executive correspondence and tasks within the FDA. The agency is interested in solutions that can streamline workflow, enhance tracking and reporting capabilities, and ensure secure and reliable management of sensitive information. The intended outcome is to identify potential products that could be implemented to improve operational efficiency and support the FDA’s mission-critical administrative functions. Key requirements highlighted in the notice include the ability to support correspondence and task management processes, with an emphasis on technical compatibility, scalability, and business suitability for the FDA’s environment. Respondents are expected to provide detailed information about their solutions, including technical specifications, business models, and any relevant experience supporting similar federal requirements. The deliverables for this RFI are informational responses that will help the FDA determine the feasibility and suitability of available COTS products for future procurement. The place of performance for this initiative is Maryland, United States, reflecting the location of the FDA’s operations. The contracting entity is the Food and Drug Administration, a federal agency under the Department of Health and Human Services. Interested parties may direct inquiries or submit responses to the designated contacts: Lilibeth Deato ([email protected]) and Min Jie Zeng ([email protected]). This notice is classified as a Special Notice and is currently active, with a response deadline set for April 3, 2026. Contractors should note that this is an RFI and not a solicitation for proposals; the FDA is seeking information only at this stage. There are no set-aside requirements or special considerations specified in the notice. The opportunity is posted on SAM.gov, with additional documentation available for review. Contractors evaluating this opportunity should consider their ability to provide proven, scalable COTS task management solutions that align with federal correspondence and workflow requirements. The scope and objectives outlined in the RFI are expected to remain constant throughout the contract lifecycle, focusing on enhancing the FDA Executive Secretariat’s operational capabilities through robust, commercially available technology.